Rigel Pharmaceuticals Newsroom

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 25 07:22 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 17 06:20 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJun 3 12:34 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaMay 8 09:38 ET

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

BenzingaMay 8 09:38 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaMar 7 11:01 ET

Citigroup Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $4

BenzingaMar 7 09:30 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaMar 6 08:38 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaFeb 22 12:25 ET

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

BenzingaJan 4 10:27 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaJan 4 10:26 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaDec 8, 2023 09:42 ET

Holding Steady: A Detailed Analysis of Rigel Pharmaceuticals' Performance and Prospects

TipRanksNov 9, 2023 13:25 ET

Rigel Pharmaceuticals Analyst Ratings

BenzingaAug 2, 2023 06:12 ET

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

BenzingaMay 3, 2023 06:31 ET

Piper Sandler Assumes Rigel Pharmaceuticals at Neutral, Announces Price Target of $2

BenzingaApr 3, 2023 09:24 ET

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

BenzingaMar 8, 2023 06:08 ET

BMO Capital Maintains Outperform on Rigel Pharmaceuticals, Lowers Price Target to $3

Benzinga Real-time NewsNov 4, 2022 10:14 ET

HC Wainwright Adjusts Rigel Pharmaceuticals' Price Target to $15 From $7, Keeps Buy Rating

MT NewswiresAug 18, 2022 22:59 ET

Rigel Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesAug 18, 2022 06:48 ET